» Articles » PMID: 35777903

Multi-omics Data Reveals the Disturbance of Glycerophospholipid Metabolism Caused by Disordered Gut Microbiota in Depressed Mice

Overview
Journal J Adv Res
Date 2022 Jul 1
PMID 35777903
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Although researchers have done intensive research on depression, its pathogenesis is still not fully explained. More and more evidence suggests that gut microbiota is closely related to the onset of depression; but its specific functional ways are not clearly identified.

Objectives: The purpose of our work was to find out how the gut microbiota was involved in the onset of depression, and to identify the potential ways to link the gut and brain in mice with depressive-like behaviors (DLB).

Methods: We used the chronic restraint stress (CRS)-induced depression model here. Gut microbiota compositions in fecal samples, lipid metabolism (in fecal, serum and hippocampus samples) and neurotransmitters in hippocampus samples were detected.

Results: We found that the 7 of 13 differential genera that significantly correlated with DLB belonged to phylum Firmicutes. The differential lipid metabolites in fecal samples mainly belonged to glycerophospholipids (GP) and fatty acids (FA) metabolism, and three important "metabolite type-bacterial taxa" correlated pairs were identified: "FA/GP-Firmicutes", "FA/GP-Akkermansia", and "FA/GP-Bifidobacterium". The key differential lipid metabolites significantly correlated with DLB mainly belonged to FA and GP, and the DLB-related metagenomic genes were consistently enriched in GP metabolism and FA metabolism. Three significantly changed short-chain fatty acids (SCFAs) were significantly correlated with the majority of differential genera. Meanwhile, we found that the differential lipid metabolites in serum and hippocampus samples were mainly mapped into the GP metabolism, and there were four differential neurotransmitters from the tryptophan pathway in hippocampus samples.

Conclusion: Together, our findings could provide novel insights into the role of "microbiota-gut-brain" (MGB) axis in depression, and indicate that the gut microbiota might have a vital role in the onset of DLB by affecting the peripheral/central GP metabolism and tryptophan pathway. The "Firmicutes-SCFAs-GP metabolism-Tryptophan pathway" might be a possible way to link the gut and brain in depressed mice.

Citing Articles

Ziziphi Spinosae Semen Flavonoid Ameliorates Hypothalamic Metabolism and Modulates Gut Microbiota in Chronic Restraint Stress-Induced Anxiety-like Behavior in Mice.

Yan Y, Zhao N, Liu J, Zhang S, Zhang Y, Qin X Foods. 2025; 14(5).

PMID: 40077533 PMC: 11898499. DOI: 10.3390/foods14050828.


Gut microbiota on anxiety and depression in primary Sjogren's syndrome: A novel insight.

Zhu Y, Zhang K, Luo Z, Song Y, Wang X Heliyon. 2025; 11(3):e42045.

PMID: 39959472 PMC: 11830307. DOI: 10.1016/j.heliyon.2025.e42045.


Faecal microbiota composition and impulsivity in a cohort of older adults with metabolic syndrome.

Konstanti P, Gomez-Martinez C, Muralidharan J, Vioque J, Corella D, Fito M Sci Rep. 2024; 14(1):28075.

PMID: 39543142 PMC: 11564772. DOI: 10.1038/s41598-024-78527-8.


Asiaticoside improves depressive-like behavior in mice with chronic unpredictable mild stress through modulation of the gut microbiota.

Ren Q, He C, Sun Y, Gao X, Zhou Y, Qin T Front Pharmacol. 2024; 15:1461873.

PMID: 39494347 PMC: 11527651. DOI: 10.3389/fphar.2024.1461873.


Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.

Potokiri A, Omeiza N, Ajayi A, Adeleke P, Alagbonsi A, Iwalewa E Curr Res Physiol. 2024; 7:100132.

PMID: 39483857 PMC: 11526068. DOI: 10.1016/j.crphys.2024.100132.


References
1.
Hao W, Wu J, Yuan N, Gong L, Huang J, Ma Q . Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice Through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon. Front Pharmacol. 2021; 12:619103. PMC: 8087337. DOI: 10.3389/fphar.2021.619103. View

2.
Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

3.
Sun L, Ma L, Zhang H, Cao Y, Wang C, Hou N . Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota. Theranostics. 2019; 9(3):721-733. PMC: 6376469. DOI: 10.7150/thno.31562. View

4.
Zhang Y, Yuan S, Pu J, Yang L, Zhou X, Liu L . Integrated Metabolomics and Proteomics Analysis of Hippocampus in a Rat Model of Depression. Neuroscience. 2017; 371:207-220. DOI: 10.1016/j.neuroscience.2017.12.001. View

5.
Chen J, Zheng P, Liu Y, Zhong X, Wang H, Guo Y . Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018; 14:647-655. PMC: 5833751. DOI: 10.2147/NDT.S159322. View